PhD-candidate, Department of Pathology, Leiden University Medical Center (LUMC)
PD-L1 expression is the most important biomarker for response to immunotherapy in advanced metastatic NSCLC. In this webinar, the development and validation of our supervised algorithm for PD-L1 scoring will be discussed.
Date: 8 December 2021 (Wednesday)
Time: New York 10:00 | London 15:00 | Paris 16:00 | Singapore 23:00 | Tokyo 00:00 (9 Dec) | Sydney 02:00 (9 Dec)
Duration: 60 minutes
Event structure: 50-min presentation + 10-min Q&A
Registration fee: Complimentary access
Webinar on-demand: Available to view until midnight 31st December 2021 (registration is required)
With over a decade of experience in hosting life science events, Global Engage is your ideal partner to either devise an agenda for you or work with you and your speakers to promote the online event to our extensive databases.